Wells Fargo Upgrades Tandem Diabetes Care to Overweight, Raises Price Target to $27
Benzinga Newsdesk 5 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Equal-Weight to Overweight and raises the price target from $21 to $27.
Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Equal-Weight to Overweight and raises the price target from $21 to $27.